References
- Zhang ZX, Roman GC. Worldwide occurrence of Parkinson’s disease: a review. Neuroepidemiology 1993; 12: 195–208.
- Quinn N. Parkinsonism - recognition and differential diagnosis. BMJ1995; 310: 447–452.
- Schapira AHV Parkinson’s disease. BMJ 1999; 318: 311–314.
- Thanvi BR, Lo TC. Long term motor complications of levodopa: clinical features, mechanisms and management strategies. Postgrad Med J 2004; 80: 452–458.
- Jost WH. Gastrointestinal motility problems in patients with Parkinson’s disease: Drugs Aging 1997; 10: 249–258.
- Richard IH, Kurlan R and the Parkinson Study Group. A survey of antidepressant drug use in Parkinson’s disease. Neurology 1997; 49:1168–1170.
- Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson’s disease with and without dementia. Relationship to age and gender. Arch Neurol 1992; 49: 492–497.
- Barichella M, Marczewska AM, Vairo A, Canesi M, Pezzoli G. Is underweightedness still a major problem in Parkinson’s disease patients ? Eur J Clin Nutr 2003; 57: 543–547.
- Guigoz Y, Vellas B, Garry PJ. Mini Nutritional Assessment: a practical assessment tool for the grading the nutritional state of elderly patients. Facts Res Gerontol 1994; 4 (Suppl 2): 15–59.
- Vellas B, Chumlea WC, Beziat F, et al. Anthropometric measures in elderly person living in Europe. L’Annèe Gerontologique/facts and research in Gerontology 1992; 6: 203–217.
- Chumlea WC, Vellas BJ, Roche AF. Particularités et intérêt des mesures anthropométriques du statut nutritionnel des personnes âgées. Age Nutr 1990; 1: 7–12.
- Chumlea WC, Roche AF, Steinbaugh RD. Estimating stature from knee height for persons to 60 to 90 years of age. J Am Geriatr Soc 1985; 33: 116–120.
- Compan B, Di Castri A, Plaze JM, Arnaud-Battander F. Epidemiological study of malnutrition in elderly patients in acute, sub-acute and long term care using the MNA. J Nutr Health Aging 1999; 3: 146–151.
- Soini H, Routasalo P, Lagstrom H. Characteristic of the Mini Nutritional Assessment in elderly home-care patients. Eur J Nutr 2004; 58: 64–70.
- Salva A, Bolibar I, Munnoz M, et al. Results of the Mini Nutritional Assessment in nursing home resident. J Am Geriatr Soc 1996; 44: P11.
- Sharkey JR. The interrelationship of nutritional risk factors, indicators of nutritional risk, and severity of disability among home-delivered meal participants. Gerontologist 2002; 42: 373–380.
- Quadri P, Fraggiacomo C, Pertoldi W, et al. Mini Nutritional Assessment and cost of care. In: Vellas B, Garry PJ, Guigoz Y. (eds) Mini Nutritional Assessment ( MNA): Research and practice in elderly, Vol 1 . Nestlé Clinical and Performance Nutrition Workshop Series. Philadelphia, PA: Lippincott-Raven, 1998; 141–148.
- Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 2007; 86: 1486–1494.
- Maguire-Zeiss KA, Short DW, Federoff HJ. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson’s disease? Brain Res Mol Brain Res 2005; 134: 18–23.
- Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C and carotenoids and the risk of Parkinson’s disease: a meta-analysis. Lancet Neurol 2005; 4: 362–365.
- Lipton SA, Kim WK, Choi YB, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 1997; 94: 5923–5928.
- Beal MF, Kowall NW, Swartz KJ, Ferrante RJ. Homocysteic acid lesions in rat striatum spare somatostatin-neuropeptide Y (NADPH-diaphorase) neurons. Neurosci Lett 1990; 108: 36–42.
- Lopez-Garcia E, Schulze MB, Fung TT, et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004; 80: 1029–1035.
- Chen H, Zhang SM, Hernan MA, et al. Nonsteroidal antiinflammatory drugs and the risk of Parkinson disease. Arch Neurol 2003; 60: 1059–1064.
- Chen H, Jacobs E, Schwarzschild MA, et al. Nonsteroidal antiinflammatory drug use and the risk of Parkinson’s disease. Ann Neurol 2005; 58: 963–967.
- Lau FC, Shukitt-Hale B, Joseph JA. Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress. SubcellBiochem 2007; 42: 299–318.